Back to Search
Start Over
Opsoclonus-Myoclonus-Associated Neuroblastoma With Bone Marrow Metastases: What Would Be the Best Treatment Option?
- Source :
-
Oncology (Williston Park, N.Y.) [Oncology (Williston Park)] 2021 Oct 22; Vol. 35 (10), pp. 665-667. Date of Electronic Publication: 2021 Oct 22. - Publication Year :
- 2021
-
Abstract
- A 1.9-year-old girl was presented to the hospital with dancing eye movements, ataxia, and behavioral disorders. The MRI showed a retroperitoneal tumor (transversal size: 3.9 x 2.5 cm, craniocaudal size: 4.6 cm) extending from T12 to L3 vertebral bodies (Figure), which was suspicious for neuroblastoma. Afterwards, biopsy of the lesion and bone marrow was performed. The initial pathological evaluation (CD56+, PHOX2B+, NKX2-, Ki67 50%-55%, NSE+, CD99-) of the tumor and bone marrow confirmed the diagnosis of poorly differentiated, high-risk neuroblastoma.
- Subjects :
- Antineoplastic Agents therapeutic use
Female
Humans
Infant, Newborn
Neuroblastoma physiopathology
Opsoclonus-Myoclonus Syndrome drug therapy
Opsoclonus-Myoclonus Syndrome physiopathology
Bone Marrow Neoplasms secondary
Neuroblastoma complications
Neuroblastoma pathology
Opsoclonus-Myoclonus Syndrome etiology
Subjects
Details
- Language :
- English
- ISSN :
- 0890-9091
- Volume :
- 35
- Issue :
- 10
- Database :
- MEDLINE
- Journal :
- Oncology (Williston Park, N.Y.)
- Publication Type :
- Academic Journal
- Accession number :
- 34677924
- Full Text :
- https://doi.org/10.46883/ONC.2021.3510.0665